Skip to Content

Join the 'High Cholesterol - Familial Heterozygous' group to help and get support from people like you.

High Cholesterol - Familial Heterozygous News

Related terms: Familial Hypercholesterolemia, Heterozygous, Heterozygous Familial Hypercholesterolemia, Heterozygous FH, Hypercholesterolemia, Familial Heterozygous

Most With Very High Cholesterol Missing Out on Right Meds

Posted 26 Mar 2018 by Drugs.com

MONDAY, March 26, 2018 – Less than 40 percent of American adults with extremely high cholesterol levels get the medications they should, a new study finds. Researchers examined federal government data to assess rates of awareness, screening and the use of cholesterol-lowering statins among adults aged 20 and older with extremely high levels of "bad" LDL cholesterol. The investigators also looked ...

High Cholesterol Tied to Better Brain Health in Those Over 85

Posted 6 Mar 2018 by Drugs.com

MONDAY, March 5, 2018 – In a seemingly counterintuitive finding, new research suggests that high cholesterol is associated with a reduced risk of mental decline in the elderly. People aged 85 to 94 with good brain function whose cholesterol was above normal had a 32 percent lower risk for mental decline over the next 10 years compared with people aged 75 to 84, who had a 50 percent higher risk ...

FDA Approves Amgen's Repatha (evolocumab) to Prevent Heart Attack and Stroke

Posted 12 Dec 2017 by Drugs.com

THOUSAND OAKS, Calif., Dec. 1, 2017 /PRNewswire/ – Amgen (NASDAQ: AMGN) today announced that following priority review of its supplemental Biologics License Application, the U.S. Food and Drug Administration (FDA) approved Repatha (evolocumab) as the first PCSK9 inhibitor to prevent heart attacks, strokes and coronary revascularizations in adults with established cardiovascular disease.1 "We ...

Health Tip: Why Get a Cholesterol Test?

Posted 28 Nov 2017 by Drugs.com

-- Cholesterol is a waxy, fatty blood substance that your body needs to keep cells healthy. It's produced by your liver and also is found in animal-based foods. There are two kinds of cholesterol: "bad" low-density lipoprotein (LDL) and "good" high-density lipoprotein (HDL). Too much "bad" cholesterol can clog your arteries and raise your risk of heart attack and stroke. Your doctor may order a ...

The 411 on High Triglycerides

Posted 25 Oct 2017 by Drugs.com

WEDNESDAY, Oct. 25, 2017 – Cholesterol might get all the attention on test results, but triglycerides are also part of the picture of good health. They're a type of fat that travels through your bloodstream. Your body gets triglycerides from fats in the foods you eat and also makes them from other types of foods, like carbohydrates. As with cholesterol, triglyceride levels are measured in ...

Many Patients Denied Costly New Cholesterol Drugs

Posted 28 Sep 2017 by Drugs.com

THURSDAY, Sept. 28, 2017 – Expensive new medicines offer hope to patients with uncontrolled "bad" cholesterol, but the high cost keeps many patients from getting them, a new study says. The injectable drugs – approved for use in the United States in 2015 – are known as PCSK9 inhibitors. They include Praluent (alirocumab) and Repatha (evolocumab). But, researchers found, of tens of thousands of ...

Powerful New Cholesterol Med Won't Harm Memory, Easing Concerns

Posted 17 Aug 2017 by Drugs.com

WEDNESDAY, Aug. 16, 2017 – Despite some early concerns, a new study suggests the powerful cholesterol drugs known as PCSK9 inhibitors may not cause memory problems or other mental symptoms. The drugs, which include evolocumab (Repatha) and alirocumab (Praluent), were approved in the United States in 2015. That came after trials showed they can dramatically slash LDL cholesterol (the "bad" kind), ...

Is the 'Anti-Statin' Trend Threatening Lives?

Posted 25 Jul 2017 by Drugs.com

MONDAY, July 24, 2017 – A wave of anti-science skepticism may put people with high cholesterol at risk if they're convinced to quit life-saving statin medications, heart experts warn. An "internet-driven cult" is attacking the safety and effectiveness of cholesterol-lowering statins, despite mounds of clinical trial data showing the drugs work and produce minimal side effects, said Dr. Steven ...

Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent (alirocumab) Injection

Posted 1 May 2017 by Drugs.com

BRIDGEWATER, N.J. and TARRYTOWN, N.Y., April 25, 2017 /PRNewswire/ – Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved the companies' new supplemental Biologics License Application (sBLA) for a once-monthly (every four weeks), 300 mg dose of Praluent (alirocumab) Injection for the treatment of adults with high low-density ...

Many Heart Attack Patients Fail to Stick With Statins

Posted 19 Apr 2017 by Drugs.com

WEDNESDAY, April 19, 2017 – High doses of powerful statin drugs have been shown to avert future heart problems, including heart attack and stroke. Yet many heart attack patients stop taking these medicines as recommended, a new study reveals. Researchers examined data for heart attack patients who had a prescription for a "high-intensity" statin filled within 30 days of being discharged from the ...

Conflicting Statin Guidelines Leave Millions in 'Gray Zone'

Posted 18 Apr 2017 by Drugs.com

TUESDAY, April 18, 2017 – Conflicting guidelines on statin use could leave about 9 million Americans unsure about treatment, a new study suggests. Researchers estimate that if all doctors followed the latest guidelines from the U.S. Preventive Services Task Force (USPSTF) for the cholesterol-lowering drugs, the number of Americans aged 40 to 75 on statin medications would rise by 16 percent. In ...

Routine Checkup Should Assess Fitness, Too

Posted 4 Jan 2017 by Drugs.com

TUESDAY, Jan. 3, 2017 – Most people know they should have their height, weight, blood pressure and cholesterol checked regularly, but an exercise expert says cardiorespiratory fitness should also be part of a routine medical exam. Cardiorespiratory fitness is a measure of how much work your body can do during exercise. "This measurement is so important because it shows how the heart, lungs and ...

Migraine and Stroke Risk Linked Again

Posted 15 Nov 2016 by Drugs.com

TUESDAY, Nov. 15, 2016 – Women who experience migraines have more than double the risk of suffering a stroke, new research shows. The finding adds evidence to the suspected link between these two conditions. Although it's not yet clear why this connection may exist, study lead author Dr. Cecil Rambarat said it's important for health care providers to be aware of the link. "This is important ...

Coming Soon: Lower Cholesterol From a Twice-a-Year Shot?

Posted 15 Nov 2016 by Drugs.com

TUESDAY, Nov. 15, 2016 – Instead of popping a pill every day, people might soon control "bad" LDL cholesterol by getting an injection at their doctor's office two or three times a year. Researchers testing a new injectable drug called Inclisiran found it cut LDL cholesterol by half or more. According to early clinical trial data, the effect could last for four to six months. Inclisiran produced ...

Parent-Child Screening Urged for Inherited Heart Condition

Posted 27 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 26, 2016 – Young children should be screened for a type of genetic heart disease that significantly increases their risk of a heart attack at a young age, a new British study suggests. The screening could also identify parents with familial hypercholesterolemia. The condition, which causes high cholesterol levels, is the main inherited cause of early heart disease, the study ...

Page 1 2 3 4 Next

Ask a Question

Further Information

Related Condition Support Groups

High Cholesterol

Related Drug Support Groups

Lipitor, simvastatin, atorvastatin, Crestor, pravastatin, lovastatin, Zetia, Zocor, rosuvastatin, view more... Vytorin, Repatha, Praluent, Pravachol, ezetimibe, Juvisync, Lescol XL, Mevacor, alirocumab, simvastatin / sitagliptin, Advicor, Lescol, Altoprev, evolocumab, Altocor, lovastatin / niacin, fluvastatin, ezetimibe / simvastatin, Repatha Pushtronex, FloLipid